Table 6.
Route of administration | Polypharmacy (all medications) | Polypharmacy (long-term medications only) | ||||
---|---|---|---|---|---|---|
Pw/oP | PwP | Statistics | Pw/oP | PwP | Statistics | |
N | 133 | 173 | 177 | 129 | ||
buccala | 0.0 (0.0) | 0.0 (0.2) | z = −1.762, p = 0.078U | 0.0 (0.2) | 0.0 (0.2) | z = −1.327, p = 0.185U |
conjunktivala | 0.0 (0.0) | 0.1 (0.3) | z = −2.957, p = 0.003U | 0.0 (0.1) | 0.1 (0.3) | z = −3.333, p = 0.001U |
cutaneousa | 0.0 (0.1) | 0.1 (0.3) | z = −2.340, p = 0.019U | 0.0 (0.1) | 0.1 (0.3) | z = −2.712, p = 0.007U |
intramusculara | 0.1 (0.2) | 0.0 (0.2) | z = −0.757, p = 0.449U | 0.1 (0.3) | 0.0 (0.2) | z = −0.856, p = 0.392U |
intravenousa | 0.4 (0.5) | 0.8 (0.7) | z = −5.141, p < 0.001U | 0.5 (0.6) | 0.8 (0.6) | z = −3.868, p < 0.001U |
nasala | 0.0 (0.1) | 0.0 (0.1) | z = −0.187, p = 0.852U | 0.0 (0.1) | 0.0 (0.1) | z = −0.225, p = 0.822U |
perorala | 1.7 (1.0) | 6.2 (2.6) | z = −14.381, p < 0.001U | 2.3 (1.5) | 6.9 (2.6) | z = −13.596, p < 0.001U |
pulmonarya | 0.0 (0.1) | 0.1 (0.2) | z = −1.307, p = 0.191U | 0.0 (0.1) | 0.1 (0.3) | z = −2.197, p = 0.028U |
rectala | 0.0 (0.0) | 0.0 (0.2) | z = −1.242, p = 0.214U | 0.0 (0.2) | 0.0 (0.1) | z = −0.220, p = 0.826U |
subcutaneousa | 0.4 (0.6) | 0.8 (0.7) | z = −5.332, p < 0.001U | 0.5 (0.6) | 0.8 (0.7) | z = −4.865, p < 0.001U |
sublinguala | 0.0 (0.1) | 0.0 (0.2) | z = −0.803, p = 0.422U | 0.0 (0.1) | 0.0 (0.2) | z = −0.038, p = 0.970U |
vaginala | 0.0 (0.0) | 0.0 (0.2) | z = −1.762, p = 0.078U | 0.0 (0.1) | 0.0 (0.1) | z = −0.319, p = 0.750U |
N, number of patients; PwP, patients with polypharmacy; Pw/oP, patients without polypharmacy.
aMean value (standard deviation) of the number of drugs taken per patient; UMann-Whitney U test.